These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11877595

  • 1. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M, Okubo M, Katori H, Nagahama K, Murase T, Kobayashi T, Tanaka S, Nakanishi K, Odawara M, Matsushita H, Yamada A.
    Am J Kidney Dis; 2002 Mar; 39(3):E15. PubMed ID: 11877595
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
    Rall SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP.
    J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
    Cautero N, Di Benedetto F, De Ruvo N, Montalti R, Guerrini GP, Ballarin R, Spaggiari M, Smerieri N, De Blasiis MG, Rompianesi G, Iemmolo RM, Marino M, Bertolotti M, Zivieri S, Gerunda GE.
    Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298
    [Abstract] [Full Text] [Related]

  • 11. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC, Lin SR, Yang YC, Chen HC, Lin JN, Shin SJ.
    J Nephrol; 2002 May; 15(4):368-73. PubMed ID: 12243365
    [Abstract] [Full Text] [Related]

  • 12. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T, Yamashita S, Yamane M, Manabe N, Matsuzaki T, Kiriyama K, Kanayama Y, Himeno S, Matsuzawa Y.
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study.
    Xin Z, Zhihong L, Shijun L, Jinfeng Z, Huiping C, Caihong Z, Daxi J, Leishi L.
    Nephrol Dial Transplant; 2009 Mar; 24(3):864-9. PubMed ID: 18840890
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M, Sasaki J, Hua H, Matsunaga A, Uchida K, Jou K, Oikawa S, Saito T, Nihei H.
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.